- A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicineWilliam G Notcutt
Pain Research Unit, James Paget University Hospital, Great Yarmouth, Norfolk, UK
Prim Health Care Res Dev 14:192-9. 2013..To identify the areas of daily function most affected by the introduction of Sativex, a cannabis-based medicine, and the impact on caregivers and people with multiple sclerosis (MS)...
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)W Notcutt
James Paget University Hospital, Pain Management Department, Gorleston on Sea, UK
Mult Scler 18:219-28. 2012..Open-label studies are not ideal for providing robust evidence for long-term maintenance of efficacy of medicines, especially where medicines provide symptom relief and where long-term use of a placebo may be problematic and not ethical...